These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 206832)

  • 21. Use of erythropoietin, active vitamin D3 metabolites, and alkali agents in predialysis patients.
    Ismail N
    Semin Nephrol; 1997 Jul; 17(4):270-84. PubMed ID: 9241713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 11. Vitamin D in the therapy of disorders of calcium and phosphorus metabolism.
    Kumar R; Riggs BL
    Mayo Clin Proc; 1981 May; 56(5):327-33. PubMed ID: 6262583
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of 1 alpha-hydroxycholecalciferol (1 alpha-OH-D3) and eel calcitonin derivative in experimental renal osteodystrophy].
    Minatoguchi T
    Nihon Jinzo Gakkai Shi; 1982 Oct; 24(10):1157-71. PubMed ID: 7161947
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of renal rickets with 1 alpha-dydroxy cholecalciferol].
    Beer SI; Vure E; Krispin C; Varon M; Taunus A; Cohen D; Mazor J
    Harefuah; 1978 Jan; 94(1):15-7. PubMed ID: 640496
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of 1 alpha-(OH)D3 on renal osteodystrophy--a 5-year retrospective evaluation].
    Kakuhara T; Mizoguchi M; Itoh M; Nagasawa M; Mori T; Ohtsuka K; Kubota M; Minatoguchi T; Ohara K; Yoshida M; Koide H; Ohno J
    Nihon Jinzo Gakkai Shi; 1982 Jun; 24(6):693-704. PubMed ID: 7176180
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of treatment with 1--alpha-hydroxyvitamin D3 in osteodystrophy in uremic patients undergoing periodical hemodialysis].
    Albertazzi A; Palmieri PF; Del Rosso G; Spisni C; Evangelista M
    Minerva Nefrol; 1980; 27(4):631-3. PubMed ID: 7254690
    [No Abstract]   [Full Text] [Related]  

  • 27. The metabolism of vitamin D; recent developments and their clinical relevance.
    Steendijk R
    Neth J Med; 1974; 17(3):131-9. PubMed ID: 4367820
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vitamin D in renal insufficiency--metabolism, hormonal forms, its effect and importance in the therapy of renal osteodystrophy].
    Labos I
    Med Arh; 1986; 40(3):101-4. PubMed ID: 3272310
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal osteodystrophy in children with chronic renal failure: an unexpectedly common and incapactating complication.
    Hsu AC; Kooh SW; Fraser D; Cumming WA; Fornasier VL
    Pediatrics; 1982 Nov; 70(5):742-50. PubMed ID: 6982452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized double blind study of 1, 25(OH)2D3 in dialysis patients.
    Maxwell DR; Benjamin DM; Donahay SL; Allen MK; Hamburger RJ; Luft FC; Kleit SA
    Proc Clin Dial Transplant Forum; 1977; 7():166-9. PubMed ID: 210446
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal osteodystrophy in children with end-stage kidney failure.
    Chan JC
    Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model for clinical research studies of renal osteodystrophy in children.
    Norman ME; Mazur A; Gruskin AB
    Arch Intern Med; 1978 May; 138 Spec No():866-8. PubMed ID: 646576
    [No Abstract]   [Full Text] [Related]  

  • 33. [1 alpha-hydroxycholecalciferol treatment of a 2-year-old child with severe renal osteodystrophy].
    Hansen HE; Christensen MS; Nielsen HE; Johannsen A
    Ugeskr Laeger; 1978 Apr; 140(16):919-21. PubMed ID: 653843
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vitamin D treatment and renal osteodystrophy: indications and modalities].
    Fournier A; Morinière P; Yverneau-Hardy P; Westeel PF; Mazouz H; el Esper N; Ghazali A; Boudailliez B
    Nephrologie; 1995; 16(2):165-90. PubMed ID: 7753302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A trial of quantitative analysis of skeletal whole body scintigraphy in renal osteo-dystrophy (author's transl)].
    Kida T; Narita S
    Kaku Igaku; 1978 Dec; 15(8):1191-6. PubMed ID: 219280
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM; Davin JC; Lambrechts L; Heynen G
    Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose vitamin D analogues for renal osteodystrophy.
    Lancet; 1989 Jun; 1(8651):1364-5. PubMed ID: 2567378
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of vitamin D on protein turnover in children with renal osteopathy].
    Denisova SN; Kutafina EK; Kon' IIa; Sergeeva TV; Savina MI
    Vopr Pitan; 1996; (6):31-4. PubMed ID: 9123919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal osteodystrophy in children: progress in its management.
    Chan JC
    Clin Pediatr (Phila); 1976 Nov; 15(11):996-1002. PubMed ID: 975714
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.